Representative before the EPO

Company dna schlich
no operation time available
897.54
2 offices
active in Legal Services

We have observed 165 EP applications George Schlich has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 18, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13744185

ALK1 ANTAGONISTS AND THEIR USES IN TREATING RENAL CELL CARCINOMA

IPC classification:
A61K 38/16, A61K 38/00, A61K 31/40
Applicant:
Beth Israel Deaconess Medical Center Inc
Agent:
George Schlich, Schlich LLP
Status:
GRANT OF PATENT INTENDED
EP13709509

METHOD AND SYSTEM TO ASSIST 2D-3D IMAGE REGISTRATION

IPC classification:
G06T 7/00
Applicant:
King's College London
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP13720491

METHODS AND USES FOR IMPROVED SOWING OF SEEDS

IPC classification:
A01C 1/06
Agent:
George Schlich, Schlich LLP
Agent:
Paul David Andrews, Murgitroyd & Company
Status:
EXAMINATION IN PROGRESS
EP13715237

LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, A PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF MULTIPLE SCLEROSIS

IPC classification:
A61K 39/00, A61K 9/127, C07K 14/47
Agent:
Icosa
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP13758471

ENGINEERED ANTIBODY-INTERFERON MUTANT FUSION MOLECULES

IPC classification:
A61K 39/395, A61K 38/21, C07K 16/30, C07K 14/56, A61P 35/00
Agent:
George Schlich, Schlich LLP
Status:
GRANT OF PATENT INTENDED
EP12874480

ISOINDOLONE DERIVATIVES

IPC classification:
A61K 31/4035, C07D 209/44, A61P 35/00
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
The patent has been granted
EP13799879

PROCESSES FOR PREPARING ESTOLIDE BASE OILS AND LUBRICANTS THAT INCLUDE TRANSESTERIFICATION

IPC classification:
C07C 69/675
Applicant:
Biosynthetic Technologies, LLC
Agent:
George Schlich, Schlich LLP
Status:
GRANT OF PATENT INTENDED
EP13796699

PROCESS FOR TREATING ORGANIC MATERIAL

IPC classification:
C02F 3/34
Agent:
George Schlich, Schlich LLP
Status:
GRANT OF PATENT INTENDED
EP13800833

SLAM LATCH

IPC classification:
E06B 11/06, E05C 19/02, E05C 1/08
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP13731212

PYRIDINONE AND PYRIDAZINONE DERIVATIVES

IPC classification:
C07D 413/10, C07D 409/04, C07D 407/12, C07D 407/04, C07D 403/12, C07D 403/10, C07D 403/04, C07D 401/14, C07D 401/12, C07D 401/10, C07D 401/04, C07D 401/02, C07D 237/14, C07D 213/81, C07D 213/74
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
The patent has been granted
EP12878861

PYRIDINONE AND PYRIDAZINONE DERIVATIVES

IPC classification:
A61K 31/351, C07D 401/14, C07D 401/12, C07D 401/06, C07D 401/02, A61P 37/00, A61P 35/00, A61P 29/00, A61P 3/10, A61P 3/04
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION IN PROGRESS
EP13709726

PROCESSES OF PREPARING ESTOLIDE COMPOUNDS THAT INCLUDE REMOVING SULFONATE RESIDUES

IPC classification:
C11C 3/14, C11C 3/08, C11C 3/00
Applicant:
Biosynthetic Technologies, LLC
Agent:
George Schlich, Schlich LLP
Status:
PATENT GRANTED
EP13807665

MICROORGANISM EVALUATION SYSTEM

IPC classification:
G01N 33/58, C12Q 1/04
Agent:
George Schlich, Schlich LLP
Status:
GRANT OF PATENT INTENDED
EP13739954

ELECTRONIC TEXTILE ASSEMBLY

IPC classification:
A61B 5/0408, A61B 5/00, A41D 13/12, A61N 1/04, A61N 1/00
Agent:
George Schlich, Schlich LLP
Status:
PATENT GRANTED
EP13737828

CANCER TREATMENT

IPC classification:
A61K 51/04, A61K 41/00, C07D 487/22, A61P 35/00
Agent:
George Schlich, Schlich LLP
Status:
PATENT GRANTED
EP13742577

COMPREHENSIVE FMR1 GENOTYPING

IPC classification:
G06F 19/18
Agent:
George Schlich, Schlich LLP
Status:
GRANT OF PATENT INTENDED
EP13759553

CONTROL OF ARTHROPOD INFESTATION

IPC classification:
A01P 7/04, A01P 7/02, A01N 57/16, A01N 25/28, A01N 25/26, A01N 25/12, A01N 25/08
Agent:
George Schlich, Schlich LLP
Agent:
Paul David Andrews, Murgitroyd & Company
Status:
GRANT OF PATENT INTENDED
EP15158384

Methods of obtaining stromal stem cells

IPC classification:
A61K 35/28, C12N 5/071
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP13771104

MODULATORS OF ANDROGEN SYNTHESIS

IPC classification:
A61K 47/30, A61K 45/06, A61K 31/58, A61K 31/519, A61K 31/473, A61K 31/454, A61K 31/202, A61K 31/201, A61K 31/20, A61P 35/00, A61P 17/10, A61P 5/28
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP13776674

USE OF P3 OF BACTERIOPHAGE FUSION PROTEINS AS AMYLOID BINDING AGENTS

IPC classification:
A61K 48/00, A61K 47/48, A61K 38/16, G01N 33/00, C07K 14/01, A61P 25/28
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP13852949

COMPOSITION CONTAINING A CELLULOSE DERIVED CAPSULE WITH A SUNSCREEN

IPC classification:
A61K 8/92, A61K 8/81, A61Q 17/04
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP13801495

PHARMACEUTICAL FORMULATIONS

IPC classification:
A61K 51/04, A61K 41/00, A61P 35/00
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14702460

SOLID SOLUTION COMPOSITIONS AND USE IN CHRONIC INFLAMMATION

IPC classification:
A61K 47/44, A61K 47/14, A61K 9/14
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP13868525

SOLUTION FOR PRESERVING VASCULAR CONDUITS

IPC classification:
A61K 38/48, A61K 31/375, A01N 1/02
Applicant:
Somahlution, LLC
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP13869369

ORGAN AND TISSUE PRESERVATION FORMULATIONS WITH INCREASED STABILITY AND SHELF LIFE

IPC classification:
A01N 1/02, A01N 1/00
Applicant:
Somahlution, LLC
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14705290

RAPID METHOD FOR DETECTION OF PATHOGEN

IPC classification:
G01N 33/569, C12Q 1/68, C12Q 1/04
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14757311

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

IPC classification:
C07D 403/04, A61P 25/06, A61K 31/4184
Agent:
George Schlich, Schlich LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14772832

CERAMIC FUEL CELL WITH ENHANCED FLATNESS AND STRENGTH AND METHODS OF MAKING SAME

IPC classification:
H01M 8/10
Applicant:
University of Maryland College Park - Office of Technology Commercialization
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14776521

SKIN COMPOSITIONS AND USES

IPC classification:
A61K 38/30
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14718832

PYRROLE AMIDE INHIBITORS

IPC classification:
A61K 31/4725, A61K 31/4704, A61K 31/4439, C07D 403/12, C07D 207/36, C07D 471/04, C07D 413/10, C07D 409/12, C07D 409/10, C07D 407/12, C07D 405/12, C07D 403/10, C07D 403/04, C07D 401/10, C07D 401/12
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
The patent has been granted
EP14730237

DIHYDRO-PYRROLOPYRIDINONE BROMODOMAIN INHIBITORS

IPC classification:
A61K 31/18, A61K 31/437, C07D 471/04
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION IN PROGRESS
EP14713019

BROMODOMAIN INHIBITORS

IPC classification:
A61P 15/06, A61P 13/00, A61P 31/18, A61P 35/00, A61K 31/519, A61K 31/5025, A61K 31/437, A61K 31/407, C07D 487/04, C07D 471/04
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION IN PROGRESS
EP14718816

FUSED TETRACYCLIC BROMODOMAIN INHIBITORS

IPC classification:
A61P 35/00, A61K 31/437, C07D 471/22, C07D 471/12
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION IN PROGRESS
EP14762617

TETRACYCLIC BROMODOMAIN INHIBITORS

IPC classification:
A61P 35/00, A61K 31/424, A61K 31/55, C07D 498/14, C07D 498/04
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION REQUESTED
EP14763444

PLANT-BASED COMPOSITIONS AND USES THEREOF

IPC classification:
C09K 8/68, E21B 43/26, C02F 1/00
Agent:
Cooley (UK) LLP
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14718403

MEDICAL USE OF SYNDECAN-2

IPC classification:
A61K 38/00, C07K 14/47
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP14797066

PROCESS FOR SIMULTANEOUS EXTRACTION AND SEPARATION OF ESTERIFIED AND UNESTERIFIED MONOHYDROXYCAROTENOIDS

IPC classification:
A01N 37/02
Applicant:
University of Maryland College Park - Office of Technology Commercialization
Agent:
George Schlich, Schlich LLP
Status:
APPLICATION WITHDRAWN
EP14737355

POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE WITH REDUCED IMMUNOGENICITY

IPC classification:
A61P 25/28, C07K 14/01, A61K 47/48, A61K 38/16
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION IN PROGRESS
EP14804529

ANTIBACTERIAL COMPOSITION AND METHOD FOR PRODUCING SAME

IPC classification:
A01N 65/08, C08L 93/00, A01P 3/00, A01N 25/10, A01N 61/00
Applicant:
Hitachi Zosen Corporation
Agent:
George Schlich, Schlich LLP
Status:
APPLICATION WITHDRAWN
EP15195678

BENZIMIDAZOLE INHIBITORS OF THE SODIUM CHANNEL

IPC classification:
C07D 241/08, C07D 401/12, C07D 413/06, C07D 413/04, C07D 403/06, C07D 403/04, C07D 401/04, C07D 211/60, C07D 207/16, C07C 237/30, C07C 237/06, A61P 29/00, A61P 25/00, A61K 31/5377, A61K 31/454, A61K 31/4458, A61K 31/4184, A61K 31/401, A61K 31/166, A61K 31/165, C07D 235/14
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
George Schlich, Schlich LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP14810526

RENAL PROGENITOR CELLS

IPC classification:
C12N 5/074, C12N 5/0735, C12N 5/071
Applicant:
The University of Queensland
Agent:
George Schlich, Schlich LLP
Status:
GRANT OF PATENT INTENDED
EP14738992

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF BRAIN METASTASIS

IPC classification:
C12Q 1/68
Applicant:
Memorial Sloan Kettering Cancer Center
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14818258

BROMODOMAIN INHIBITORS

IPC classification:
A61P 35/00, A61K 31/18, A61P 31/00, A61K 31/437, C07D 471/06
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
GRANT OF PATENT INTENDED
EP14741844

SMOKED FOOD, METHOD FOR SMOKING FOOD AND APPARATUS THEREFOR

IPC classification:
A23L 27/27, A23L 5/20, A23B 4/052
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14812052

SOLUTONS FOR INCREASING THE STABILITY AND SHELF LIFE OF AN ORGAN TISSUE PRESERVATION SOLUTION

IPC classification:
A01N 1/02
Applicant:
Somahlution, LLC
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14749984

METHOD AND SYSTEM FOR TOMOSYNTHESIS IMAGING

IPC classification:
G06T 11/00
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14834331

SHOE WITH MAGNETIC ATTACHMENT MECHANISM

IPC classification:
A43B 3/24
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14748357

SPRING CLIP BOTTOM LOADING POLYAXIAL BALL AND SOCKET FASTENER

IPC classification:
A61B 17/70
Agent:
George Schlich, Schlich LLP
Status:
GRANT OF PATENT INTENDED
EP14772109

DIAGNOSIS OF FOETAL DISTRESS

IPC classification:
G01N 33/53, G01N 33/50
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14793793

VERTICAL AXIS WIND TURBINE WITH PROTECTIVE SCREEN

IPC classification:
F03D 3/04, F03D 7/06
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14793792

LUGGAGE CONTROL AND VERIFICATION SYSTEM AND METHODS OF USE

IPC classification:
B64F 1/36
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14814779

DYNAMIC ROLLOVER PROTECTION SYSTEM

IPC classification:
B60R 21/013
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14860998

METHODS OF USE FOR IL-22 IN THE TREATMENT OF GASTROINTESTINAL GRAFT VS. HOST DISEASE

IPC classification:
C07K 14/00, C07K 1/00, A61K 38/00, A61K 45/00
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14800124

CELL CULTURE SYSTEM

IPC classification:
C12M 1/12, C12M 1/00, C12N 5/00, C12N 5/0775
Applicant:
Loughborough University - Enterprise Office
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14857152

COMPOSITIONS AND METHODS FOR MODULATING NEURONAL EXCITABILITY AND MOTOR BEHAVIOR

IPC classification:
A61K 48/00
Applicant:
The Rockefeller University
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15707568

SELECTION AND USE OF STEM CELLS

IPC classification:
C12N 5/077, C12N 5/0775
Applicant:
National University of Ireland, Galway (National University of Ireland Galway)
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15707303

SERUM-FREE MEDIUM

IPC classification:
C12N 5/0775, C12N 5/00
Applicant:
National University of Ireland, Galway (National University of Ireland Galway)
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14868187

FLAVOR-IMPROVING ENZYME COMPOSITION, METHOD FOR SUPPRESSING OCCURRENCE OF UNPLEASANT ODOR, AND METHOD FOR MANUFACTURING FOOD WITH REDUCED UNPLEASANT ODOR

IPC classification:
C12N 15/09, A23L 15/00, A23L 27/60, A23G 3/34, A23G 3/00, A21D 13/00, A21D 2/34, C12N 9/16
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP14827852

NOVEL OPIOID COMPOUNDS AND THEIR USES

IPC classification:
A61P 25/30, A61P 25/24, A61K 31/439, C07D 489/02
Applicant:
Sri International Inc
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP16168473

GLYCOPOLYSIALYLATION OF PROTEINS OTHER THAN BLOOD COAGULATION PROTEINS

IPC classification:
A61K 47/48
Applicant:
Baxalta GmbH
Applicant:
Baxalta Incorporated
Agent:
Icosa
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP14868965

BROMODOMAIN INHIBITORS

IPC classification:
A61P 3/10, A61P 31/18, A61P 13/12, A61P 35/00, A61K 31/4353, C07D 491/22
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
EXAMINATION REQUESTED
EP14824247

DIHYDROPYRIDINONE AND DIHYDROPYRIDAZINONE DERIVATIVES USEFUL AS BROMODOMAIN INHIBITORS

IPC classification:
A61P 35/00, A61K 31/4412, C07D 213/69, C07D 487/04, C07D 417/12, C07D 413/12, C07D 405/12, C07D 401/12
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
The patent has been granted
EP15751291

CROSSLINKED NUCLEOSIDE AND NUCLEOTIDE

IPC classification:
C12N 15/09, C07H 21/00, C07H 19/02
Applicant:
Osaka University
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15755760

HETEROCYCLIC INHIBITORS OF THE SODIUM CHANNEL

IPC classification:
C07C 237/24, C07C 237/20, C07C 237/14, C07C 237/08, A61P 29/00, A61P 25/08, A61P 25/06, A61P 25/02, A61K 31/5375, A61K 31/498, A61K 31/496, A61K 31/495, A61K 31/454, A61K 31/4465, A61K 31/4458, A61K 31/4184, A61K 31/4166, A61K 31/404, A61K 31/40, A61K 31/165, C07D 235/04
Agent:
George Schlich, Schlich LLP
Agent:
Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP15739309

CONTROL OF ARTHROPOD INFESTATION

IPC classification:
A01N 59/00, A01N 65/40, A01N 63/04, A01N 25/12
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP14887943

ENGINEERED THREE-DIMENSIONAL BREAST TISSUE, ADIPOSE TISSUE, AND TUMOR DISEASE MODEL

IPC classification:
C12N 5/09
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15773780

COHESIVENESS-IMPROVING AGENT FOR BREAD OR OTHER GRAIN FLOUR PUFFED FOOD PRODUCTS

IPC classification:
A21D 2/26
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP15180256

SOLID SOLUTION COMPOSITIONS FOR NSAID

IPC classification:
A61K 31/192, A61K 9/48, A61K 9/14, A61K 47/14, A61K 47/10
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP15783450

TREATMENT OF H-RAS-DRIVEN TUMORS

IPC classification:
C07K 14/82
Applicant:
Memorial Sloan Kettering Cancer Center
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP16183412

ACTIVATED SIALIC ACID DERIVATIVES FOR PROTEIN DERIVATISATION AND CONJUGATION

IPC classification:
C08B 37/00
Agent:
Icosa
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16194210

ELECTRONIC TEXTILE ASSEMBLY

IPC classification:
A61N 1/04, A41D 1/00, A61B 5/0408, A41D 13/12
Agent:
George Schlich, Schlich LLP
Status:
APPLICATION PUBLISHED
EP15819217

PRODUCING LITHIUM

IPC classification:
C25C 7/04
Agent:
George Schlich, Schlich LLP
Status:
EXAMINATION REQUESTED
EP16201264

TARGET POPULATIONS OF OLIGODENDROCYTE PRECURSOR CELLS AND METHODS OF MAKING AND USING SAME

IPC classification:
C12N 5/0797, C12N 5/079
Agent:
George Schlich, Schlich LLP
Status:
APPLICATION PUBLISHED
EP15840245

SOLUTION DELIVERY DEVICE AND METHOD

IPC classification:
A61J 1/20
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP15784441

SELF-ASSEMBLING TRIPEPTIDES

IPC classification:
G06F 19/16, B82Y 40/00, C07K 5/087, C07K 5/09
Applicant:
University of Strathclyde
Agent:
George Schlich, Schlich LLP
Agent:
Paul Gilmour Chapman, Marks & Clerk
Status:
Request for examination was made
EP15843630

METHODS OF DETECTING ADENOSINE DEAMINASE DEFICIENCY

IPC classification:
G01N 33/58, G01N 33/49, G01N 33/483, G01N 33/48, C12Q 1/34, C12N 1/34
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP15848294

ENGINEERED RENAL TISSUES, ARRAYS THEREOF, AND METHODS OF MAKING THE SAME

IPC classification:
G01N 33/50, C12N 5/09, C12N 5/07
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP15854018

USE OF BMP4 FOR THYMIC REGENERATION

IPC classification:
C12N 15/34, C12N 5/071, C12N 5/10
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP15831011

POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE LACKING A GLYCOSYLATION SIGNAL

IPC classification:
A61K 38/16, C07K 14/005
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP15823857

BCL-XL INHIBITORY COMPOUNDS AND ANTIBODY DRUG CONJUGATES INCLUDING THE SAME

IPC classification:
A61P 35/00, A61K 31/429, A61K 31/428, C07D 513/04, C07D 417/14
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
Request for examination was made
EP15813671

BCL XL INHIBITORY COMPOUNDS HAVING LOW CELL PERMEABILITY AND ANTIBODY DRUG CONJUGATES INCLUDING THE SAME

IPC classification:
A61P 35/00, A61K 31/429, A61K 31/428, C07D 513/04, C07D 417/14
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
Request for examination was made
EP15819955

ANTIBODY DRUG CONJUGATES WITH CELL PERMEABLE BCL-XL INHIBITORS

IPC classification:
A61P 35/00, A61P 43/00, A61K 47/50
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
Micaela Modiano, Modiano & Partners
Status:
Request for examination was made
EP15868703

DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO FORM RENAL ORGANOIDS

IPC classification:
C12N 5/0735, C12N 5/071
Applicant:
The University of Queensland
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16744200

METHODS AND BIOMARKERS FOR DETECTION AND TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS

IPC classification:
C12Q 1/68, C12N 9/12, C12N 1/21
Applicant:
University of Michigan
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16704157

APPARATUS FOR TREATMENT OF SNORING AND SLEEP APNOEA

IPC classification:
A61N 1/36
Applicant:
King's College London
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP16707667

DIGITAL IMAGE REMAPPING

IPC classification:
G06T 11/00, G06T 7/00, G06T 5/50, A61B 6/00, A61B 6/12, A61B 6/02
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16758983

ENDOSCOPE HANGER, ENDOSCOPE HOLDING METHOD, AND CART, CLEANING SINK, CLEANING AND DISINFECTING DEVICE, STAND, AND ENDOSCOPE STORAGE CABINET HAVING SAID ENDOSCOPE HANGER

IPC classification:
G02B 23/24, A61B 1/12, A61B 1/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16761744

EVAPORATION DEVICE

IPC classification:
B01F 15/06, B01F 15/02, B01F 7/16, B01D 5/00, B01D 1/22
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16774227

METHODS FOR TREATING OBESITY AND NONALCOHOLIC FATTY LIVER DISEASE OR NONALCOHOLIC STEATOHEPATITIS USING GLUCAGON RECEPTOR ANTAGONISTIC ANTIBODIES

IPC classification:
C12P 21/08
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16718951

INDAZOLONES AS MODULATORS OF TNF SIGNALING

IPC classification:
A61P 29/00, A61P 37/00, A61P 35/00, A61P 27/14, A61P 3/00, A61P 9/00, A61K 31/5383, A61K 31/541, A61K 31/5377, A61K 31/506, C07D 519/00, C07D 498/04, C07D 487/04
Agent:
George Schlich, Schlich LLP
Agent:
D Young & Co LLP
Status:
Request for examination was made
EP16720752

TREATMENT OF BACTERIAL INFECTIONS IN AQUACULTURE

IPC classification:
A23K 50/80, A61P 31/04, A61K 35/76
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16783603

NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS FOR TREATING MUSCLE WASTING DISEASES

IPC classification:
A61K 38/17, C07K 14/51, C07K 14/495, C07K 14/47, C07K 14/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16721023

TRICYCLIC MODULATORS OF TNF SIGNALING

IPC classification:
A61P 37/00, A61K 31/437, C07D 519/00, C07D 498/22, C07D 498/20, C07D 498/18, C07D 498/14, C07D 498/04, C07D 487/04, C07D 471/14, C07D 471/04
Agent:
George Schlich, Schlich LLP
Agent:
D Young & Co LLP
Status:
Request for examination was made
EP17194182

METHODS AND DEVICES FOR CELLULAR TRANSPLANTATION

IPC classification:
C12N 5/071, A61M 39/02, A61L 27/58, A61K 35/12, A61L 27/54, A61F 2/02, A61L 27/38, A61L 27/56, A61L 27/16
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16788948

ANIMAL ENCLOSURE

IPC classification:
E04H 17/00, E06B 11/02, E06B 11/08, A01K 1/00, A01K 3/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP15891040

NK CELLS AND ANTIBODIES FOR CANCER TREATMENT

IPC classification:
A61P 35/02, A61P 35/00, A61K 35/17, A61K 39/395
Applicant:
University Health Network (UHN)
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16718189

INDAZOLONES AS MODULATORS OF TNF SIGNALING

IPC classification:
C07D 498/04, C07D 491/107, C07D 487/04, C07D 417/14, C07D 417/04, C07D 403/14, C07D 403/04, C07D 401/04, C07D 413/14, C07D 405/14, C07D 401/14
Agent:
George Schlich, Schlich LLP
Agent:
D Young & Co LLP
Status:
Request for examination was made
EP16802289

DELIVERY OF STRUCTURALLY DIVERSE POLYPEPTIDE CARGO INTO MAMMALIAN CELLS BY A BACTERIAL TOXIN

IPC classification:
C12N 9/52, C12N 9/48, C12N 9/10, C12N 15/62, C12N 15/09, C07K 14/34, A61P 25/00, A61K 47/48, A61K 38/48, A61K 38/45, A61K 38/16, A61K 35/74, C07K 19/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17196375

SMOKED FOOD, METHOD FOR SMOKING FOOD AND APPARATUS THEREFOR

IPC classification:
A23L 27/27, A23L 5/20, A23B 4/052
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16731721

NUCLEAR RECEPTOR MODULATORS

IPC classification:
A61P 37/00, A61P 29/00, A61K 31/416, A61K 31/404, C07D 209/18, C07D 209/14, C07D 491/10, C07D 487/04, C07D 471/04, C07D 405/10, C07D 403/10, C07D 235/16, C07D 401/10, C07D 405/14
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Agent:
D Young & Co LLP
Status:
The patent has been granted
EP16808391

FOCUSED INTERFERON IMMUNOTHERAPY FOR TREATMENT OF CANCER

IPC classification:
C07K 19/00, C07K 16/30, C07K 14/565, C07K 14/56, A61K 38/21
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16750677

MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES HAVING INCREASED CYTOTOXICITY

IPC classification:
C12N 15/63, A61K 35/17, C12N 5/0783
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP16833623

PRODRUGS OF GLUTAMINE ANALOGS

IPC classification:
A61K 31/7076, A61K 31/66, A61K 31/404, C07D 317/40, C07F 9/06, C07D 209/10, C07C 227/14
Applicant:
Johns Hopkins University
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16833633

METHODS AND COMPOSITIONS FOR TREATING METABOLIC REPROGRAMMING DISORDERS

IPC classification:
A61K 45/06, A61K 31/404, A61K 31/421, A61K 31/357, A61K 31/66, A61K 31/198
Applicant:
Johns Hopkins University
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16835850

EXERCISE SYSTEM AND METHOD

IPC classification:
A63B 71/00, A63B 69/00, A63B 26/00, A63B 23/00, A63B 21/002
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16839956

NON-TOXIC PEST CONTROL COMPOSITIONS AND METHODS AND USES THEREOF

IPC classification:
C07D 303/32, C07C 49/242, C07C 39/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16839958

NON-TOXIC PLANT AGENT COMPOSITIONS AND METHODS AND USES THEREOF

IPC classification:
C11D 1/66, A01N 63/02, C12N 1/18, C07K 14/395, A01N 63/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16839957

PAPERMAKING ADDITIVE COMPOSITIONS AND METHODS AND USES THEREOF

IPC classification:
C08G 79/02
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16843107

SMALL MOLECULE INHIBITORS OF DYRK1A AND USES THEREOF

IPC classification:
A61K 31/43, C07D 487/04, C07D 513/04, A01N 43/00
Agent:
George Schlich, Schlich LLP
Agent:
Tom Hugo Wittop Koning, Biopatents IP Consultancy
Status:
Request for examination was made
EP16843103

METHODS FOR TREATING HEART FAILURE USING GLUCAGON RECEPTOR ANTAGONISTIC ANTIBODIES

IPC classification:
A61P 9/10, A61K 45/06, A61K 39/395, A61K 38/26
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16840481

MODIFIERS OF CFTR-DIRECTED THERAPY

IPC classification:
C07K 14/705, G01N 33/53, G01N 33/50, C12Q 1/68, C12Q 1/02, C07D 271/06, C07D 215/56, C07D 213/75, A61K 48/00, A61K 31/47, A61K 31/44, A61K 31/4245, G01N 33/48
Applicant:
The Hospital For Sick Children
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16845102

MUSCARINIC COMBINATIONS AND THEIR USE FOR COMBATING HYPOCHOLINERGIC DISORDERS OF THE CENTRAL NERVOUS SYSTEM

IPC classification:
A61P 25/28, A61P 25/24, A61P 25/18, A61P 25/14, A61P 25/00, A61K 31/435
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16844229

EVAPORATOR

IPC classification:
B01F 7/16, B01D 1/22, B01D 1/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16845090

MUSCARINIC COMBINATION AND ITS USE FOR COMBATING HYPOCHOLINERGIC DISORDERS OF THE CENTRAL NERVOUS SYSTEM

IPC classification:
A61P 25/28, A61P 25/24, A61P 25/18, A61P 25/14, A61P 25/00, A61K 31/435
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP15884844

RECOVERY AND PROCESSING OF HUMAN EMBRYOS FORMED IN VIVO

IPC classification:
A61B 17/435
Agent:
George Schlich, Schlich LLP
Agent:
John Conroy, Fish & Richardson PC
Status:
Request for examination was made
EP17195000

BROMODOMAIN INHIBITORS

IPC classification:
A61P 3/10, A61P 13/12, A61P 31/18, A61P 35/00, A61K 31/407, C07D 471/04
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16865230

NONWOVEN WITH IMPROVED ABRASION RESISTANCE AND METHOD OF MAKING THE SAME

IPC classification:
D01F 6/06, D04H 1/4291, D04H 3/00
Agent:
Veronika Zemanová, Kania Sedlák Smola
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16865236

NONWOVEN COMPOSITE INCLUDING NATURAL FIBER WEB LAYER AND METHOD OF FORMING THE SAME

IPC classification:
D04H 1/425, A47L 13/16, B32B 29/02, B32B 5/06, B32B 5/02
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16866996

RECOVERY AND PROCESSING OF HUMAN EMBRYOS FORMEDIN VIVO

IPC classification:
A61M 3/02, A61K 31/575, A61K 31/57, A61B 17/435, A61B 17/42
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16810282

PROCESS FOR MAKING GRANULES AND AGGLOMERATES FROM POWDERS

IPC classification:
C05B 17/00, C05B 11/10, C05B 11/08
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP16878061

POLYLACTIC ACID RESIN COMPOSITION AND METHOD FOR PRODUCING SAME

IPC classification:
C08L 101/16, C08L 9/00, C08K 5/14, C08J 3/24, C08L 67/04
Applicant:
Hitachi Zosen Corporation
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP18187137

MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES HAVING INCREASED CYTOTOXICITY

IPC classification:
C12N 15/63, A61K 35/17, C12N 5/0783
Agent:
George Schlich, Schlich LLP
Status:
Examination is in progress
EP17771215

TREATMENT OF CANCER WITH TG02

IPC classification:
C07D 498/06, A61K 31/535
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP18194107

MODIFIED NATURAL KILLER CELLS AND NATURAL KILLER CELL LINES HAVING INCREASED CYTOTOXICITY

IPC classification:
A61K 39/00, C12N 15/85, C12N 15/113, A61K 31/69, C12N 15/63, A61K 35/17, C12N 5/0783
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17719387

LIPID NANOPARTICLE FORMULATIONS FOR CRISPR/CAS COMPONENTS

IPC classification:
C12N 5/071, C12N 15/11, C12N 9/22, A61K 48/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17718290

MDM2 PROTEIN DEGRADERS

IPC classification:
A61P 35/00, A61K 31/4745, C07D 487/10, C07D 401/04
Applicant:
University of Michigan
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17718291

MONOFUNCTIONAL INTERMEDIATES FOR LIGAND-DEPENDENT TARGET PROTEIN DEGRADATION

IPC classification:
A61P 35/00, A61K 31/4745, C07D 401/04, C07D 487/10
Applicant:
University of Michigan
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17781931

BROMODOMAIN INHIBITORS

IPC classification:
A61P 3/10, A61P 13/12, A61P 31/18, A61P 35/00, A61K 31/437, A61K 31/407, C07D 487/04, C07D 471/04
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17186683

IMPROVED CANCER TREATMENT USING NK CELLS

IPC classification:
A61K 45/06, A61P 35/02, A61K 35/17, A61K 31/675, A61K 31/454, A61K 39/395, C07K 16/28
Agent:
George Schlich, Schlich LLP
Status:
The application has been published
EP17721544

CHAGAS ANTIGENS AND ANTIBODIES AND COMPOSITIONS, METHODS AND USES THEREOF

IPC classification:
C07K 14/44, A61K 39/005
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17717993

BET PROTEIN DEGRADERS

IPC classification:
A61P 35/00, A61K 31/4745, C07D 487/04
Applicant:
University of Michigan
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17722552

COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES ASSOCIATED WITH TRINUCLEOTIDE REPEATS IN TRANSCRIPTION FACTOR FOUR

IPC classification:
A61K 48/00, A61K 47/00, A61K 38/46, A61K 31/7105
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17722968

PIPERIDINES AS MENIN INHIBITORS

IPC classification:
A61P 35/00, A61K 31/4545, A61K 31/454, A61K 31/4523, C07D 211/34, C07D 405/04, C07D 401/14, C07D 401/04
Applicant:
University of Michigan
Applicant:
The Regents of the University of Michigan - U-M Tech Transfer
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17825774

ENGINEERED NATURAL KILLER CELLS AND USES THEREOF

IPC classification:
A61P 35/00, A61K 39/00, A61K 35/15
Agent:
George Schlich, Schlich LLP
Status:
The patent has been granted
EP17732657

ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

IPC classification:
A61K 39/00, A61K 31/00, C07K 16/28
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Examination is in progress
EP17193898

ANTI-BACTERIAL PACKAGING

IPC classification:
A23B 7/155, A23B 4/22, A23L 3/3571
Agent:
George Schlich, Schlich LLP
Status:
The application has been published
EP17739735

ANTI-EGFR ANTIBODY DRUG CONJUGATES

IPC classification:
C07K 16/28, A61P 35/00, A61K 47/68
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17731394

ANTI-EGFR ANTIBODY DRUG CONJUGATES

IPC classification:
A61P 43/00, A61P 35/00, A61K 47/68, C07K 16/28
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17739740

ANTI-EGFR ANTIBODY DRUG CONJUGATES

IPC classification:
C07K 16/28, A61P 35/00, A61K 47/68
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17731045

ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

IPC classification:
A61P 35/00, A61K 39/00, A61K 31/337, A61K 47/68, C07K 16/28
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17732658

ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

IPC classification:
A61P 35/00, A61K 39/00, A61K 31/337, A61K 47/68, C07K 16/28
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17739393

ANTI-CD98 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

IPC classification:
A61K 47/68, C07K 16/28, A61K 31/337, A61K 39/395
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17732382

PROTEIN PRODUCTION IN PLANT CELLS

IPC classification:
C12N 15/82
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17816061

SMALL MOLECULE INHIBITORS OF ALDH AND USES THEREOF

IPC classification:
A61K 31/519, A61K 31/277, A61K 31/136
Applicant:
University of Michigan
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17758952

SUBSTITUTED THIAZOLO-PYRIDINE COMPOUNDS AS MALT1 INHIBITORS

IPC classification:
A61P 19/00, A61P 17/00, A61P 37/00, A61P 35/00, A61K 31/429, C07D 513/04
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17761037

METHOD FOR SMOKING LIQUIDS AND DEVICE THEREFOR

IPC classification:
A23L 27/27
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17734649

SEED COATINGS COMPRISING PESTICIDE

IPC classification:
A01P 7/00, A01P 5/00, A01P 3/00, A01N 47/40, A01N 43/54, A01N 31/06, A01N 25/10, A01N 25/08, A01N 25/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17849755

HIV CLINICAL PLAN

IPC classification:
C07K 14/47, C07K 14/16, C12N 9/22
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17856516

ORTHOTIC APPLIANCE

IPC classification:
A63B 71/08, A61F 13/06, A61F 5/37, A61F 5/01
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17859181

METHODS AND SYSTEMS FOR AUGMENTING IMMUNE SYSTEM RESPONSES

IPC classification:
A61K 39/00, A61K 38/19, A61K 38/00, A61K 35/12, A61K 9/00, A61J 9/00, A61J 1/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP19156612

METHODS FOR MAKING GRILL-TYPE SMOKED FOOD INGREDIENTS

IPC classification:
A23B 4/048
Agent:
George Schlich, Schlich LLP
Status:
The application has been published
EP16918654

BROMODOMAIN INHIBITORS

IPC classification:
A61P 35/00, A61K 31/4412, C07D 417/12, C07D 413/12, C07D 405/12, C07D 401/12, C07D 401/14, C07D 403/12
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP18156552

METHOD FOR MAKING GRILL-TYPE SMOKED FOOD INGREDIENTS

IPC classification:
A23B 4/048
Agent:
George Schlich, Schlich LLP
Status:
The application has been withdrawn
EP18157487

DOWNSTREAM MODIFIED WASTE DISPOSAL APPARATUS

IPC classification:
F23G 5/00, F23J 1/08, F23J 9/00
Agent:
George Schlich, Schlich LLP
Status:
The application has been published
EP16918992

BROMODOMAIN INHIBITORS

IPC classification:
A61P 29/00, A61P 31/18, A61P 35/00, A61K 31/4412, C07D 401/04, C07D 237/14, C07D 213/68, C07D 213/50
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17861941

METHODS FOR TREATING MUSCLE WASTING AND BONE DISEASE USING NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS

IPC classification:
A61P 19/00, A61P 9/12, A61P 9/10, A61P 9/00, A61P 3/00, A61K 38/18, A61K 38/17
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17868625

BIOPRINTED HAIR FOLLICLES AND USES THEREOF

IPC classification:
A61L 27/60, A61L 27/38, A61L 27/24
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17870550

ENGINEERED INTESTINAL TISSUE AND USES THEREOF

IPC classification:
A61K 35/12, A61K 35/15, C12N 5/16, C12N 5/078, C12N 5/071
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP19156935

TETRACYCLIC BROMODOMAIN INHIBITORS

IPC classification:
A61P 15/16, A61P 13/12, A61P 31/18, A61P 35/00, A61K 31/55, C07D 471/22
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
The application has been published
EP17821748

5,6-DIHYDRO-11H-INDOLO[2,3-B]QUINOLIN-11-ONES AS ALK INHIBITORS

IPC classification:
A61K 31/437, A61P 35/00, C07D 471/04
Applicant:
University of Michigan
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP19162206

INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING

IPC classification:
A61P 1/00, A61P 17/06, A61K 31/4353, C07D 487/04
Applicant:
AbbVie Inc
Agent:
George Schlich, Schlich LLP
Status:
The application has been published
EP17825416

IMPROVED NK-BASED CELL THERAPY

IPC classification:
A61K 39/395, C12N 15/113, C07K 14/00, A61K 35/17, A61K 31/00, C07K 16/24, A61P 35/00
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17835903

COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTITRYPSIN DEFICIENCY

IPC classification:
C12N 15/113
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17883876

CASPASE-1 INHIBITION AND USES THEREOF FOR PREVENTION AND TREATMENT OF NEUROLOGICAL CONDITIONS

IPC classification:
A61P 25/28, A61K 45/00, A61K 38/05
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made
EP17887964

TREATMENT OF HEMATOLOGICAL MALIGNANCY WITH SMALL MOLECULE NF-KB INHIBITORS

IPC classification:
C07D 491/04, A61K 31/519
Agent:
George Schlich, Schlich LLP
Status:
Request for examination was made

Please Sign in to use this feature